Abstract
Exosomes are nanoscale extracellular vesicles secreted by exocytosis and affect both physiological and pathological mechanisms. Exosomes are important mediators and therapeutic targets of diabetes mellitus and pancreatic cancer owing to their role in controlling β-cell mass and insulin signaling. Early diagnosis of diabetes and pancreatic cancer can remarkably expand therapeutic approaches and overall survival. Further, identification of biomarkers for predicting the risk of diabetes and pancreatic cancer development and monitoring of their progression to disease state could be useful in envisaging possible complications along with prevention and treatment. Recently, exosomes are recognized as apparent facilitators of intercellular communication. They are reported as novel source of potential biomarkers. Current knowledge on exosome content can further aid in the development of potential markers for diagnosis and prognosis of diabetes and pancreatic cancer and also for discovery of novel therapeutic targets. This chapter covers the current updates on the role of exosomes in types 1 and 2 diabetes as well as pancreatic cancer. The later sections cover the role of exosome in diagnosis, drug delivery, and treatment of diabetes and pancreatic cancer along with their future prospects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- ADSCs:
-
Adipose-derived stem cells
- CSF:
-
Cerebrospinal fluid
- DC:
-
Dendritic cells
- LADA:
-
Latent autoimmune diabetes
- MODY:
-
Monogenic maturity onset diabetes
- MSC:
-
Mesenchymal stem cell
- PP cells:
-
Pancreatic polypeptide cells
- RI:
-
Resistance to insulin
- T1D:
-
Type I diabetes
- T2D:
-
Type II diabetes
References
Zhang Y, Liu Y, Liu H, Tang WH (2019) Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci 9:19
Menay F, Herschlik L, De Toro J, Cocozza F, Tsacalian R, Gravisaco MJ, Di Sciullo MP, Vendrell A, Waldner CI, Mongini C (2017) Exosomes isolated from ascites of T-cell lymphoma-bearing mice expressing surface CD24 and HSP-90 induce a tumor-specific immune response. Front Immunol 8:286
Willms E, Johansson HJ, Mager I, Lee Y, Blomberg KE, Sadik M, Alaarg A, Smith CI, Lehtio J, El Andaloussi S, Wood MJ, Vader P (2016) Cells release subpopulations of exosomes with distinct molecular and biological properties. Sci Rep 6:22519
Maia J, Caja S, Strano Moraes MC, Couto N, Costa-Silva B (2018) Exosome-based cell-cell communication in the tumor microenvironment. Front Cell Dev Biol 6:18
Wu R, Gao W, Yao K, Ge J (2019) Roles of exosomes derived from immune cells in cardiovascular diseases. Front Immunol 10:648
Silva AM, Teixeira JH, Almeida MI, Goncalves RM, Barbosa MA, Santos SG (2017) Extracellular vesicles: immunomodulatory messengers in the context of tissue repair/regeneration. Eur J Pharm Sci 98:86–95
Anel A, Gallego-Lleyda A, de Miguel D, Naval J, Martinez-Lostao L (2019) Role of exosomes in the regulation of T-cell mediated immune responses and in autoimmune disease. Cells 8(2):E154
Gao D, Jiang L (2018) Exosomes in cancer therapy: a novel experimental strategy. Am J Cancer Res 8:2165–2175
Zhang C, Ji Q, Yang Y, Li Q, Wang Z (2018) Exosome: function and role in Cancer metastasis and drug resistance. Technol Cancer Res Treat 17:1533033818763450
Geis-Asteggiante L, Belew AT, Clements VK, Edwards NJ, Ostrand-Rosenberg S, El-Sayed NM, Fenselau C (2018) Differential content of proteins, mRNAs, and miRNAs suggests that MDSC and their exosomes may mediate distinct immune suppressive functions. J Proteome Res 17:486–498
Malla RR, Pandrangi S, Kumari S, Gavara MM, Badana AK (2018) Exosomal tetraspanins as regulators of cancer progression and metastasis and novel diagnostic markers. Asia Pac J Clin Oncol 14:383–391
Yang Q, Diamond MP, Al-Hendy A (2016) The emerging role of extracellular vesicle-derived miRNAs: implication in cancer progression and stem cell related diseases. J Clin Epigenet 2(1):13
Willms E, Cabanas C, Mager I, Wood MJA, Vader P (2018) Extracellular vesicle heterogeneity: subpopulations, isolation techniques, and diverse functions in cancer progression. Front Immunol 9:738
Yan Y, Fu G, Ming L (2018) Role of exosomes in pancreatic cancer. Oncol Lett 15:7479–7488
Guay C, Regazzi R (2017) Exosomes as new players in metabolic organ cross-talk. Diabetes Obes Metab 19(Suppl 1):137–146
Tan L, Wu H, Liu Y, Zhao M, Li D, Lu Q (2016) Recent advances of exosomes in immune modulation and autoimmune diseases. Autoimmunity 49:357–365
Garcia-Contreras M, Brooks RW, Boccuzzi L, Robbins PD, Ricordi C (2017) Exosomes as biomarkers and therapeutic tools for type 1 diabetes mellitus. Eur Rev Med Pharmacol Sci 21:2940–2956
Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A (2006) The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A 103:2334–2339
Figliolini F, Cantaluppi V, De Lena M, Beltramo S, Romagnoli R, Salizzoni M, Melzi R, Nano R, Piemonti L, Tetta C, Biancone L, Camussi G (2014) Isolation, characterization and potential role in Beta cell-endothelium cross-talk of extracellular vesicles released from human pancreatic islets. PLoS One 9:e102521
Koh DS, Cho JH, Chen L (2012) Paracrine interactions within islets of Langerhans. J Mol Neurosci 48:429–440
Bennet WM, Wang ZL, Jones PM, Wang RM, James RF, London NJ, Ghatei MA, Bloom SR (1996) Presence of neuropeptide Y and its messenger ribonucleic acid in human islets: evidence for a possible paracrine role. J Clin Endocrinol Metab 81:2117–2120
Rodriguez-Diaz R, Menegaz D, Caicedo A (2014) Neurotransmitters act as paracrine signals to regulate insulin secretion from the human pancreatic islet. J Physiol 592:3413–3417
Guay C, Menoud V, Rome S, Regazzi R (2015) Horizontal transfer of exosomal microRNAs transduce apoptotic signals between pancreatic beta-cells. Cell Commun Signal 13:17
Lee HS, Jeong J, Lee KJ (2009) Characterization of vesicles secreted from insulinoma NIT-1 cells. J Proteome Res 8:2851–2862
Palmisano G, Jensen SS, Le Bihan MC, Laine J, McGuire JN, Pociot F, Larsen MR (2012) Characterization of membrane-shed microvesicles from cytokine-stimulated beta-cells using proteomics strategies. Mol Cell Proteomics 11:230–243
Zhu Q, Kang J, Miao H, Feng Y, Xiao L, Hu Z, Liao DF, Huang Y, Jin J, He S (2014) Low-dose cytokine-induced neutral ceramidase secretion from INS-1 cells via exosomes and its anti-apoptotic effect. FEBS J 281:2861–2870
Ibrahim M, Tuomilehto J, Aschner P, Beseler L, Cahn A, Eckel RH, Fischl AH, Guthrie G, Hill JO, Kumwenda M, Leslie RD, Olson DE, Pozzilli P, Weber SL, Umpierrez GE (2018) Global status of diabetes prevention and prospects for action: a consensus statement. Diabetes Metab Res Rev 34:e3021
Kharroubi AT, Darwish HM (2015) Diabetes mellitus: the epidemic of the century. World J Diabetes 6:850–867
Kahn BB, Flier JS (2000) Obesity and insulin resistance. J Clin Invest 106:473–481
Yoon JW, Jun HS (2005) Autoimmune destruction of pancreatic beta cells. Am J Ther 12:580–591
Wang Z, Xie Z, Lu Q, Chang C, Zhou Z (2017) Beyond genetics: what causes type 1 diabetes. Clin Rev Allergy Immunol 52:273–286
Durinovic-Bello I (1998) Autoimmune diabetes: the role of T cells. Autoimmunity 27:159–177
McGinty JW, Marre ML, Bajzik V, Piganelli JD, James EA (2015) T cell epitopes and post-translationally modified epitopes in type 1 diabetes. Curr Diab Rep 15:90
Delong T, Wiles TA, Baker RL, Bradley B, Barbour G, Reisdorph R, Armstrong M, Powell RL, Reisdorph N, Kumar N, Elso CM, DeNicola M, Bottino R, Powers AC, Harlan DM, Kent SC, Mannering SI, Haskins K (2016) Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion. Science (New York, NY) 351:711–714
Sheng H, Hassanali S, Nugent C, Wen L, Hamilton-Williams E, Dias P, Dai YD (1950) Insulinoma-released exosomes or microparticles are immunostimulatory and can activate autoreactive T cells spontaneously developed in nonobese diabetic mice. J Immunol (Baltimore, MD) 187(2011):1591–1600
Bashratyan R, Sheng H, Regn D, Rahman MJ, Dai YD (2013) Insulinoma-released exosomes activate autoreactive marginal zone-like B cells that expand endogenously in prediabetic NOD mice. Eur J Immunol 43:2588–2597
Vomund AN, Zinselmeyer BH, Hughes J, Calderon B, Valderrama C, Ferris ST, Wan X, Kanekura K, Carrero JA, Urano F, Unanue ER (2015) Beta cells transfer vesicles containing insulin to phagocytes for presentation to T cells. Proc Natl Acad Sci U S A 112:E5496–E5502
Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110
Ge Q, Gerard J, Noel L, Scroyen I, Brichard SM (2012) MicroRNAs regulated by adiponectin as novel targets for controlling adipose tissue inflammation. Endocrinology 153:5285–5296
Thomou T, Mori MA, Dreyfuss JM, Konishi M, Sakaguchi M, Wolfrum C, Rao TN, Winnay JN, Garcia-Martin R, Grinspoon SK, Gorden P, Kahn CR (2017) Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature 542:450–455
Jayabalan N, Nair S, Nuzhat Z, Rice GE, Zuniga FA, Sobrevia L, Leiva A, Sanhueza C, Gutierrez JA, Lappas M, Freeman DJ, Salomon C (2017) Cross talk between adipose tissue and placenta in obese and gestational diabetes mellitus pregnancies via exosomes. Front Endocrinol 8:239
Herder C, Schneitler S, Rathmann W, Haastert B, Schneitler H, Winkler H, Bredahl R, Hahnloser E, Martin S (2007) Low-grade inflammation, obesity, and insulin resistance in adolescents. J Clin Endocrinol Metab 92:4569–4574
Kranendonk ME, Visseren FL, van Balkom BW, Nolte-’t Hoen EN, van Herwaarden JA, de Jager W, Schipper HS, Brenkman AB, Verhaar MC, Wauben MH, Kalkhoven E (2014) Human adipocyte extracellular vesicles in reciprocal signaling between adipocytes and macrophages. Obesity (Silver Spring, Md) 22:1296–1308
Deng ZB, Poliakov A, Hardy RW, Clements R, Liu C, Liu Y, Wang J, Xiang X, Zhang S, Zhuang X, Shah SV, Sun D, Michalek S, Grizzle WE, Garvey T, Mobley J, Zhang HG (2009) Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance. Diabetes 58:2498–2505
Ying W, Riopel M, Bandyopadhyay G, Dong Y, Birmingham A, Seo JB, Ofrecio JM, Wollam J, Hernandez-Carretero A, Fu W, Li P, Olefsky JM (2017) Adipose tissue macrophage-derived exosomal miRNAs can modulate in vivo and in vitro insulin sensitivity. Cell 171:372–384.e312
Yu Y, Du H, Wei S, Feng L, Li J, Yao F, Zhang M, Hatch GM, Chen L (2018) Adipocyte-derived exosomal MiR-27a induces insulin resistance in skeletal muscle through repression of PPARgamma. Theranostics 8:2171–2188
Kranendonk ME, Visseren FL, van Herwaarden JA, Nolte-’t Hoen EN, de Jager W, Wauben MH, Kalkhoven E (2014) Effect of extracellular vesicles of human adipose tissue on insulin signaling in liver and muscle cells. Obesity (Silver Spring, Md) 22:2216–2223
Vallabhajosyula P, Korutla L, Habertheuer A, Yu M, Rostami S, Yuan CX, Reddy S, Liu C, Korutla V, Koeberlein B, Trofe-Clark J, Rickels MR, Naji A (2017) Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest 127:1375–1391
Kalani A, Mohan A, Godbole MM, Bhatia E, Gupta A, Sharma RK, Tiwari S (2013) Wilm’s tumor-1 protein levels in urinary exosomes from diabetic patients with or without proteinuria. PLoS One 8:e60177
Musante L, Tataruch D, Gu D, Liu X, Forsblom C, Groop PH, Holthofer H (2015) Proteases and protease inhibitors of urinary extracellular vesicles in diabetic nephropathy. J Diabetes Res 2015:289734
Barutta F, Tricarico M, Corbelli A, Annaratone L, Pinach S, Grimaldi S, Bruno G, Cimino D, Taverna D, Deregibus MC, Rastaldi MP, Perin PC, Gruden G (2013) Urinary exosomal microRNAs in incipient diabetic nephropathy. PLoS One 8:e73798
Katome T, Namekata K, Mitamura Y, Semba K, Egawa M, Naito T, Harada C, Harada T (2015) Expression of intraocular peroxisome proliferator-activated receptor gamma in patients with proliferative diabetic retinopathy. J Diabetes Complicat 29:275–281
Tsukita S, Yamada T, Takahashi K, Munakata Y, Hosaka S, Takahashi H, Gao J, Shirai Y, Kodama S, Asai Y, Sugisawa T, Chiba Y, Kaneko K, Uno K, Sawada S, Imai J, Katagiri H (2017) MicroRNAs 106b and 222 improve hyperglycemia in a mouse model of insulin-deficient diabetes via pancreatic beta-cell proliferation. EBioMedicine 15:163–172
Kamalden TA, Macgregor-Das AM, Kannan SM, Dunkerly-Eyring B, Khaliddin N, Xu Z, Fusco AP, Yazib SA, Chow RC, Duh EJ, Halushka MK, Steenbergen C, Das S (2017) Exosomal MicroRNA-15a transfer from the pancreas augments diabetic complications by inducing oxidative stress. Antioxid Redox Signal 27:913–930
Cianciaruso C, Phelps EA, Pasquier M, Hamelin R, Demurtas D, Alibashe Ahmed M, Piemonti L, Hirosue S, Swartz MA, De Palma M, Hubbell JA, Baekkeskov S (2017) Primary human and rat beta-cells release the intracellular autoantigens GAD65, IA-2, and proinsulin in exosomes together with cytokine-induced enhancers of immunity. Diabetes 66:460–473
Cai J, Han Y, Ren H, Chen C, He D, Zhou L, Eisner GM, Asico LD, Jose PA, Zeng C (2013) Extracellular vesicle-mediated transfer of donor genomic DNA to recipient cells is a novel mechanism for genetic influence between cells. J Mol Cell Biol 5:227–238
Saari H, Lazaro-Ibanez E, Viitala T, Vuorimaa-Laukkanen E, Siljander P, Yliperttula M (2015) Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of paclitaxel in autologous prostate cancer cells. J Control Release 220:727–737
Ohno S, Takanashi M, Sudo K, Ueda S, Ishikawa A, Matsuyama N, Fujita K, Mizutani T, Ohgi T, Ochiya T, Gotoh N, Kuroda M (2013) Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther 21:185–191
Pashoutan Sarvar D, Shamsasenjan K, Akbarzadehlaleh P (2016) Mesenchymal stem cell-derived exosomes: new opportunity in cell-free therapy. Adv Pharm Bull 6:293–299
Favaro E, Carpanetto A, Lamorte S, Fusco A, Caorsi C, Deregibus MC, Bruno S, Amoroso A, Giovarelli M, Porta M, Perin PC, Tetta C, Camussi G, Zanone MM (2014) Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes. Diabetologia 57:1664–1673
Favaro E, Carpanetto A, Caorsi C, Giovarelli M, Angelini C, Cavallo-Perin P, Tetta C, Camussi G, Zanone MM (2016) Human mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients. Diabetologia 59:325–333
Cui C, Ye X, Chopp M, Venkat P, Zacharek A, Yan T, Ning R, Yu P, Cui G, Chen J (2016) miR-145 regulates diabetes-bone marrow stromal cell-induced Neurorestorative effects in diabetes stroke rats. Stem Cells Transl Med 5:1656–1667
Wen D, Peng Y, Liu D, Weizmann Y, Mahato RI (2016) Mesenchymal stem cell and derived exosome as small RNA carrier and Immunomodulator to improve islet transplantation. J Control Release 238:166–175
Oh K, Kim SR, Kim DK, Seo MW, Lee C, Lee HM, Oh JE, Choi EY, Lee DS, Gho YS, Park KS (2015) In vivo differentiation of therapeutic insulin-producing cells from bone marrow cells via extracellular vesicle-mimetic Nanovesicles. ACS Nano 9:11718–11727
Zhao H, Shang Q, Pan Z, Bai Y, Li Z, Zhang H, Zhang Q, Guo C, Zhang L, Wang Q (2018) Exosomes from adipose-derived stem cells attenuate adipose inflammation and obesity through polarizing M2 macrophages and Beiging in white adipose tissue. Diabetes 67:235–247
Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66:7–30
Iacobuzio-Donahue CA (2012) Genetic evolution of pancreatic cancer: lessons learnt from the pancreatic cancer genome sequencing project. Gut 61:1085–1094
Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, Kamiyama M, Hruban RH, Eshleman JR, Nowak MA, Velculescu VE, Kinzler KW, Vogelstein B, Iacobuzio-Donahue CA (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467:1114–1117
Falasca M, Kim M, Casari I (2016) Pancreatic cancer: current research and future directions. Biochim Biophys Acta 1865:123–132
Lou G, Song X, Yang F, Wu S, Wang J, Chen Z, Liu Y (2015) Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma. J Hematol Oncol 8:122
Hong BS, Cho JH, Kim H, Choi EJ, Rho S, Kim J, Kim JH, Choi DS, Kim YK, Hwang D, Gho YS (2009) Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BMC Genomics 10:556
Beloribi-Djefaflia S, Siret C, Lombardo D (2015) Exosomal lipids induce human pancreatic tumoral MiaPaCa-2 cells resistance through the CXCR4-SDF-1alpha signaling axis. Oncoscience 2:15–30
Takikawa T, Masamune A, Yoshida N, Hamada S, Kogure T, Shimosegawa T (2017) Exosomes derived from pancreatic stellate cells: MicroRNA signature and effects on pancreatic Cancer cells. Pancreas 46:19–27
Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, Xiang J, Zhang T, Theilen TM, Garcia-Santos G, Williams C, Ararso Y, Huang Y, Rodrigues G, Shen TL, Labori KJ, Lothe IM, Kure EH, Hernandez J, Doussot A, Ebbesen SH, Grandgenett PM, Hollingsworth MA, Jain M, Mallya K, Batra SK, Jarnagin WR, Schwartz RE, Matei I, Peinado H, Stanger BZ, Bromberg J, Lyden D (2015) Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol 17:816–826
Liu Y, Gu Y, Cao X (2015) The exosomes in tumor immunity. Oncoimmunology 4:e1027472
Amedei A, Niccolai E, Prisco D (2014) Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy. Hum Vaccin Immunother 10:3354–3368
Hori SI, Herrera A, Rossi JJ, Zhou J (2018) Current advances in aptamers for Cancer diagnosis and therapy. Cancer 10(1):E9
Janssen LME, Ramsay EE, Logsdon CD, Overwijk WW (2017) The immune system in cancer metastasis: friend or foe? J Immunother Cancer 5:79
Ding G, Zhou L, Qian Y, Fu M, Chen J, Chen J, Xiang J, Wu Z, Jiang G, Cao L (2015) Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p. Oncotarget 6:29877–29888
Kamisawa T, Wood LD, Itoi T, Takaori K (2016) Pancreatic cancer. Lancet (London, England) 388:73–85
Sagar G, Sah RP, Javeed N, Dutta SK, Smyrk TC, Lau JS, Giorgadze N, Tchkonia T, Kirkland JL, Chari ST, Mukhopadhyay D (2016) Pathogenesis of pancreatic cancer exosome-induced lipolysis in adipose tissue. Gut 65:1165–1174
Javeed N, Sagar G, Dutta SK, Smyrk TC, Lau JS, Bhattacharya S, Truty M, Petersen GM, Kaufman RJ, Chari ST, Mukhopadhyay D (2015) Pancreatic cancer-derived exosomes cause paraneoplastic beta-cell dysfunction. Clin Cancer Res 21:1722–1733
Patel GK, Patton MC, Singh S, Khushman M, Singh AP (2016) Pancreatic cancer exosomes: shedding off for a meaningful journey. Pancreat Disord Ther 6:e148
Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C, Gutberlet K, Kettner E, Schmalenberg H, Weigang-Koehler K, Bechstein WO, Niedergethmann M, Schmidt-Wolf I, Roll L, Doerken B, Riess H (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267–277
Corcoran C, Rani S, O’Brien K, O’Neill A, Prencipe M, Sheikh R, Webb G, McDermott R, Watson W, Crown J, O’Driscoll L (2012) Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes. PLoS One 7:e50999
Wei Y, Lai X, Yu S, Chen S, Ma Y, Zhang Y, Li H, Zhu X, Yao L, Zhang J (2014) Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells. Breast Cancer Res Treat 147:423–431
Yu S, Cao H, Shen B, Feng J (2015) Tumor-derived exosomes in cancer progression and treatment failure. Oncotarget 6:37151–37168
Richards KE, Zeleniak AE, Fishel ML, Wu J, Littlepage LE, Hill R (2017) Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells. Oncogene 36:1770–1778
Nonaka T, Wong DTW (2017) Saliva-Exosomics in Cancer: molecular characterization of cancer-derived exosomes in saliva. Enzyme 42:125–151
Huang T, Deng CX (2019) Current progresses of exosomes as cancer diagnostic and prognostic biomarkers. Int J Biol Sci 15:1–11
Paoli D, Pecora G, Pallotti F, Faja F, Pelloni M, Lenzi A, Lombardo F (2019) Cytological and molecular aspects of the ageing sperm. Hum Reprod (Oxford, England) 34:218–227
Sun Z, Shi K, Yang S, Liu J, Zhou Q, Wang G, Song J, Li Z, Zhang Z, Yuan W (2018) Effect of exosomal miRNA on cancer biology and clinical applications. Mol Cancer 17:147
Li LM, Liu H, Liu XH, Hu HB, Liu SM (2019) Clinical significance of exosomal miRNAs and proteins in three human cancers with high mortality in China. Oncol Lett 17:11–22
Lu L, Risch HA (2016) Exosomes: potential for early detection in pancreatic cancer. Future Oncol (London, England) 12:1081–1090
Joshi GK, Deitz-McElyea S, Liyanage T, Lawrence K, Mali S, Sardar R, Korc M (2015) Label-free Nanoplasmonic-based short noncoding RNA sensing at attomolar concentrations allows for quantitative and highly specific assay of MicroRNA-10b in biological fluids and circulating exosomes. ACS Nano 9:11075–11089
Madhavan B, Yue S, Galli U, Rana S, Gross W, Muller M, Giese NA, Kalthoff H, Becker T, Buchler MW, Zoller M (2015) Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity. Int J Cancer 136:2616–2627
Herreros-Villanueva M, Bujanda L (2016) Glypican-1 in exosomes as biomarker for early detection of pancreatic cancer. Ann Transl Med 4:64
Lucien F, Lac V, Billadeau DD, Borgida A, Gallinger S, Leong HS (2019) Glypican-1 and glycoprotein 2 bearing extracellular vesicles do not discern pancreatic cancer from benign pancreatic diseases. Oncotarget 10:1045–1055
Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Mark MT, Molina H, Kohsaka S, Di Giannatale A, Ceder S, Singh S, Williams C, Soplop N, Uryu K, Pharmer L, King T, Bojmar L, Davies AE, Ararso Y, Zhang T, Zhang H, Hernandez J, Weiss JM, Dumont-Cole VD, Kramer K, Wexler LH, Narendran A, Schwartz GK, Healey JH, Sandstrom P, Labori KJ, Kure EH, Grandgenett PM, Hollingsworth MA, de Sousa M, Kaur S, Jain M, Mallya K, Batra SK, Jarnagin WR, Brady MS, Fodstad O, Muller V, Pantel K, Minn AJ, Bissell MJ, Garcia BA, Kang Y, Rajasekhar VK, Ghajar CM, Matei I, Peinado H, Bromberg J, Lyden D (2015) Tumour exosome integrins determine organotropic metastasis. Nature 527:329–335
Moutinho-Ribeiro P, Macedo G, Melo SA (2018) Pancreatic cancer diagnosis and management: has the time come to prick the bubble? Front Endocrinol 9:779
Nuzhat Z, Kinhal V, Sharma S, Rice GE, Joshi V, Salomon C (2017) Tumour-derived exosomes as a signature of pancreatic cancer - liquid biopsies as indicators of tumour progression. Oncotarget 8:17279–17291
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Deepak KGK, Malla, R.R. (2019). Exosomes: Mediators and Therapeutic Targets of Diabetes and Pancreatic Cancer. In: Nagaraju, G., BM Reddy, A. (eds) Exploring Pancreatic Metabolism and Malignancy. Springer, Singapore. https://doi.org/10.1007/978-981-32-9393-9_14
Download citation
DOI: https://doi.org/10.1007/978-981-32-9393-9_14
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-32-9392-2
Online ISBN: 978-981-32-9393-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)